Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the ten analysts that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation, six have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $131.00.
Several brokerages have issued reports on ADUS. Weiss Ratings cut Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 22nd. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Stephens reduced their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 25th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Wednesday, February 25th. Finally, Wall Street Zen lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st.
Read Our Latest Report on ADUS
Hedge Funds Weigh In On Addus HomeCare
Addus HomeCare Trading Down 0.1%
NASDAQ ADUS opened at $94.71 on Wednesday. The company has a market capitalization of $1.77 billion, a price-to-earnings ratio of 17.51, a price-to-earnings-growth ratio of 1.30 and a beta of 0.89. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. Addus HomeCare has a 12 month low of $87.95 and a 12 month high of $124.43. The company’s fifty day moving average price is $93.86 and its two-hundred day moving average price is $102.86.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The company had revenue of $363.50 million during the quarter, compared to the consensus estimate of $366.41 million. During the same quarter in the previous year, the firm earned $1.42 EPS. The company’s revenue was up 7.7% on a year-over-year basis. As a group, research analysts predict that Addus HomeCare will post 6.24 earnings per share for the current fiscal year.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
See Also
- Five stocks we like better than Addus HomeCare
- Flying Under the Radar: Lockheed Martin’s $2.8B Stealth Setup
- Bread’s Comeback Is Real—But Is the Easy Money Gone?
- Ollie’s Stock Has Lagged Despite Earnings Beats—What’s Holding It Back?
- Fox Captures The Living Room With $22B Roku Buy
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
